Replimune prices $100.5M IPO in middle of range

Replimune Group Inc. (NASDAQ:REPL) raised $100.5 million late July 19 through the sale of 6.7 million shares at $15 in an IPO underwritten by J.P. Morgan, Leerink and BMO Capital Markets. The price, which was in the middle of Replimune's proposed range of $14-$16, valued the company at $462.6 million.

Replimune’s seed investors were Omega Funds and Forbion Capital Partners; Atlas Venture led the company’s $30 million series A round in 2015. Other shareholders include Bain Capital and Foresite Capital...